|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.015 AUD | -6.25% |
|
-16.67% | -37.50% |
| May. 13 | Transcript : HeraMED Limited - Special Call | |
| May. 08 | HeraMED Obtains ASIC Approval for Extension to Hold 2024 Meeting | MT |
HeraMED Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was USD 0.139995 million compared to USD 0.021215 million a year ago. Net loss was USD 3.16 million compared to USD 1.74 million a year ago.
Basic loss per share from continuing operations was USD 0.0161 compared to USD 0.0102 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -37.50% | 3.77M | |
| -7.79% | 3.07B | |
| +5.23% | 190M | |
| -14.72% | 84.6M | |
| +13.04% | 52.99M |
HERAMED LIMITED 